Treatment Failures of Direct Oral Anticoagulants
Conclusions:
Our analysis illustrates that DOACs may fail in the setting of Food and Drug Administration and non–Food and Drug Administration- approved indications. In clinical practice, it may be best to choose between available anticoagulant drugs on a case-by-case basis.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Meta-analysis Source Type: research
More News: Antiphospholipid Syndrome | Atrial Fibrillation | Drugs & Pharmacology | Hughes Syndrome | Ischemic Stroke | Pradaxa | Pulmonary Thromboembolism | Stroke | Study | Thrombosis | Vitamin K | Vitamins